Literature DB >> 33169181

Serum prolidase, malondialdehyde and catalase levels for the evaluation of oxidative stress in patients with peripheral vertigo.

Isa Ozbay1, Muhammet Fatih Topuz2, Fatih Oghan3, Havva Kocak4, Cuneyt Kucur5.   

Abstract

PURPOSE: We aimed to evaluate oxidative stress in patients with peripheral vertigo by measuring serum prolidase, malondialdehyde (MDA) and catalase levels.
METHODS: A total of 30 patients (age: 60 <) with peripheral vertigo and 30 healthy subjects were recruited. Blood samples were collected from both groups and serum prolidase levels were measured using enzyme-linked immunosorbent assay (ELISA). MDA and catalase levels were measured by the spectrophotometric method.
RESULTS: The most common cause of vertigo was BPPV (53.3%), followed by Ménière's disease (16.6%), vestibular neuritis (13.3%), lateral semicircular canal fistula (3.3%), and idiopathic vertigo (13.3%). Mean serum prolidase activity and MDA levels were significantly higher in the vertigo patients than in the control subjects (P < 0.05); however, there was no statistically significant difference in mean serum catalase levels between the groups (P > 0.05).
CONCLUSION: We concluded that serum prolidase and MDA levels may be used as markers of oxidative stress in patients with peripheral vertigo.

Entities:  

Keywords:  Catalase; Malondialdehyde; Oxidative stress; Peripheral vertigo; Prolidase

Year:  2020        PMID: 33169181     DOI: 10.1007/s00405-020-06466-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  1 in total

1.  Elevated red cell distribution width predicts residual dizziness in patients with benign paroxysmal positional vertigo.

Authors:  Ke-Hang Xie; Li-Chun Chen; Ling-Ling Liu; Chu-Yin Su; Hua Li; Run-Ni Liu; Qing-Qing Chen; Jia-Sheng He; Yong-Kun Ruan; Wang-Kai He
Journal:  Front Neurol       Date:  2022-09-01       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.